HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Allan, C. M. Articles by Taylor, J. M. Search for Related Content PubMed PubMed Citation Articles by Allan, C. M. Articles by Taylor, J. M. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 1510-1518, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice

CM Allan and JM Taylor
Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94141- 9100, USA.

The human apolipoprotein (apo) C-IV gene has been recently identified: it is closely linked to the promoter region of the apoC-II gene (Allan, C.M., D. Walker, J. Segrest, and J. M. Taylor. 1995. Genomics. 28: 291- 300). To determine the effect of apoC-IV gene expression on lipoprotein metabolism, transgenic mice were generated using a human apoC-IV cDNA construct. Human apoC-IV was found associated with plasma lipoproteins (d < 1.21 g/ml), mainly in very low density lipoproteins (VLDL), and higher molecular mass isoforms were present, due to N-linked glycosylation and variable sialylation of apoC-IV. Human apoC-IV transgenic mice were hypertriglyceridemic compared to nontransgenic controls; the accumulated plasma triglycerides were present mainly in VLDL. There was little change in plasma cholesterol levels, although apoC-IV expression redistributed cholesterol to VLDL and larger particles in low density lipoprotein/large high density lipoprotein fractions. By immunoblot analysis, apoC-IV was not detected in normal adult human plasma or isolated plasma lipoproteins, a finding consistent with our previous observation of very low levels of human apoC-IV mRNA in human liver. However, our analysis of transgenic mice provides unequivocal evidence that human apoC-IV is a lipid-binding protein belonging to the apolipoprotein family and that it has the potential to alter lipoprotein metabolism.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. S. Muise, B. Azzolina, D. W. Kuo, M. El-Sherbeini, Y. Tan, X. Yuan, J. Mu, J. R. Thompson, J. P. Berger, and K. K. Wong Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor {gamma} and Altered Metabolic States Mol. Pharmacol., August 1, 2008; 74(2): 403 - 412. [Abstract] [Full Text] [PDF]

				M. Ricote, A. F. Valledor, and C. K. Glass Decoding Transcriptional Programs Regulated by PPARs and LXRs in the Macrophage: Effects on Lipid Homeostasis, Inflammation, and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 230 - 239. [Abstract] [Full Text]

				L. Kotite, L-H. Zhang, Z. Yu, A. L. Burlingame, and R. J. Havel Human apoC-IV: isolation, characterization, and immunochemical quantification in plasma and plasma lipoproteins J. Lipid Res., July 1, 2003; 44(7): 1387 - 1394. [Abstract] [Full Text] [PDF]

				P. A. Mak, B. A. Laffitte, C. Desrumaux, S. B. Joseph, L. K. Curtiss, D. J. Mangelsdorf, P. Tontonoz, and P. A. Edwards Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human Macrophages. A CRITICAL ROLE FOR NUCLEAR LIVER X RECEPTORS alpha AND beta J. Biol. Chem., August 23, 2002; 277(35): 31900 - 31908. [Abstract] [Full Text] [PDF]

				L. A. Pennacchio, M. Olivier, J. A. Hubacek, J. C. Cohen, D. R. Cox, J.-C. Fruchart, R. M. Krauss, and E. M. Rubin An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing Science, October 5, 2001; 294(5540): 169 - 173. [Abstract] [Full Text] [PDF]

				M. C. Jong, M. H. Hofker, and L. M. Havekes Role of ApoCs in Lipoprotein Metabolism : Functional Differences Between ApoC1, ApoC2, and ApoC3 Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 472 - 484. [Full Text] [PDF]

				C. M. Allan, S. Taylor, and J. M. Taylor Two Hepatic Enhancers, HCR.1 and HCR.2, Coordinate the Liver Expression of the Entire Human Apolipoprotein E/C-I/C-IV/C-II Gene Cluster J. Biol. Chem., November 14, 1997; 272(46): 29113 - 29119. [Abstract] [Full Text] [PDF]